Status:
UNKNOWN
A Clinical Study on the Prevention of Mild to Moderate Intermittent Asthma With Chinese Medicine Weiyang Yuping Fang
Lead Sponsor:
Shanghai University of Traditional Chinese Medicine
Conditions:
Bronchial Asthma
Eligibility:
All Genders
18-65 years
Phase:
PHASE2
Brief Summary
Clinical exploring study of Weiyang Yuping Decoction in preventing acute attacks of mild to moderate intermittent asthma Based on the theory of "Preventing disease from exacerbating" in Chinese medici...
Detailed Description
Based on the preliminary clinical and basic research, this project intends to highly optimize and integrate the TCM treatment of disease theory with the current methods to form two preventive treatmen...
Eligibility Criteria
Inclusion
- Diagnosis of asthma according to GINA criteria with a documented history of at least 3 years prior to Visit 1
- Patients have asthma exacerbations every year
- Meet the diagnostic criteria for mild to moderate asthma
- Able to measure lung ventilation function according to ATS (American Thoracic Society) standards
- Patients who have given written informed consent
Exclusion
- Medical history of life-threatening asthma including intubation and intensive care unit admission
- Any significant disease or disorder (e.g., cardiovascular, pulmonary other than asthma, gastrointestinal, hepatic, renal, neurological, musculoskeletal, endocrine, metabolic, malignant, psychiatric, major physical impairment) which, in the opinion of the investigator, may either put the patient at risk because of participation in the study, or may influence the results of the study, or the patient's ability to participate in the study
- Pregnancy, breast-feeding or planned pregnancy during the study.
- Participation in another clinical study or took other research drugs during the last 30 days prior to Visit 1
- Known or suspected hypersensitivity to study drugs or excipient
- Suspected poor capability, as judged by the investigator, of following instructions of the study.
Key Trial Info
Start Date :
October 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2024
Estimated Enrollment :
84 Patients enrolled
Trial Details
Trial ID
NCT04522726
Start Date
October 1 2020
End Date
December 30 2024
Last Update
May 25 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Longhua Hospital Affiliated Shanghai University of TCM
Shanghai, Shanghai Municipality, China, 200032